DANIEL HALL: Open Payments
NPI 1508369224 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $171 |
| Dexcom, Inc. | 6 | $119 |
| IBSA Pharma Inc. | 5 | $84 |
| Lilly USA, LLC | 4 | $83 |
| Exact Sciences Corporation | 4 | $83 |
| Renalytix AI, Inc. | 2 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| ABBVIE INC. | 2 | $29 |
Products named: Ozempic, Dexcom G6 Transmitter, Tirosint, MOUNJARO, Cologuard Collection Kit, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT, GEMTESA, UBRELVY.
Industry payments across TX — which companies pay providers there.
